Company intelligence / Profile preview

H.I.G. BioHealth Partners

Miami, Florida, United States

Ownership: Private
Development stage: Other

Overview

H.I.G. BioHealth Partners, formerly H.I.G. BioVentures, is the dedicated life-science investment affiliate of H.I.G. Capital. It functions as a private equity and venture capital firm specializing in healthcare and life sciences, rather than developing products itself. The firm invests in therapeutics, medical devices, diagnostics, pharmaceutical services, and digital health, with investments ranging from $5 million to $40 million. It has a portfolio of 74 investments and 15 exits, with approximately $400 million in committed capital.

Industry: Investors

Beyond the preview

Go deeper on H.I.G. BioHealth Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on H.I.G. BioHealth Partners.

Explore the full profile